tiprankstipranks
Trending News
More News >
Abbvie (ABBV)
:ABBV
US Market

AbbVie (ABBV) Ratios

Compare
22,554 Followers

AbbVie Ratios

ABBV's free cash flow for Q4 2024 was $0.71. For the 2024 fiscal year, ABBV's free cash flow was decreased by $ and operating cash flow was $-0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.66 0.87 0.96 0.79 0.84
Quick Ratio
0.55 0.76 0.84 0.70 0.73
Cash Ratio
0.14 0.34 0.31 0.28 0.29
Solvency Ratio
0.10 0.11 0.17 0.15 0.08
Operating Cash Flow Ratio
0.49 0.60 0.84 0.65 0.61
Short-Term Operating Cash Flow Coverage
2.76 3.18 6.03 1.82 2.07
Net Current Asset Value
$ -106.22B$ -91.31B$ -93.06B$ -103.17B$ -113.30B
Leverage Ratios
Debt-to-Assets Ratio
0.50 0.44 0.46 0.52 0.57
Debt-to-Equity Ratio
20.19 5.73 3.67 4.98 6.58
Debt-to-Capital Ratio
0.95 0.85 0.79 0.83 0.87
Long-Term Debt-to-Capital Ratio
0.95 0.83 0.77 0.81 0.86
Financial Leverage Ratio
40.65 13.00 8.04 9.51 11.51
Debt Service Coverage Ratio
1.61 1.69 4.68 1.80 1.82
Interest Coverage Ratio
3.25 5.74 8.12 7.40 4.63
Debt to Market Cap
0.21 0.22 0.22 0.32 0.48
Interest Debt Per Share
39.63 34.85 36.99 44.69 53.10
Net Debt to EBITDA
4.13 2.69 1.72 2.37 3.67
Profitability Margins
Gross Profit Margin
69.99%62.42%70.00%68.96%66.41%
EBIT Margin
11.58%15.85%27.06%27.42%12.78%
EBITDA Margin
26.47%31.86%54.13%50.32%46.17%
Operating Profit Margin
16.22%23.49%31.21%31.89%24.81%
Pretax Profit Margin
6.60%11.51%23.21%23.11%7.42%
Net Profit Margin
7.59%8.95%20.39%20.54%10.08%
Continuous Operations Profit Margin
7.61%8.97%20.40%20.55%10.09%
Net Income Per EBT
115.12%77.81%87.82%88.86%135.84%
EBT Per EBIT
40.67%48.99%74.39%72.47%29.90%
Return on Assets (ROA)
3.17%3.61%8.53%7.88%3.07%
Return on Equity (ROE)
128.66%46.94%68.60%74.91%35.30%
Return on Capital Employed (ROCE)
9.48%13.17%16.58%16.10%9.32%
Return on Invested Capital (ROIC)
10.21%9.56%14.04%12.87%5.57%
Return on Tangible Assets
10.66%10.39%30.19%30.22%13.35%
Earnings Yield
1.36%1.77%4.14%4.82%2.58%
Efficiency Ratios
Receivables Turnover
5.16 4.87 5.16 5.63 5.19
Payables Turnover
5.74 5.54 5.94 6.05 6.76
Inventory Turnover
4.04 4.98 4.87 5.58 4.65
Fixed Asset Turnover
10.97 10.89 11.76 11.00 8.73
Asset Turnover
0.42 0.40 0.42 0.38 0.30
Working Capital Turnover Ratio
-6.26 -18.37 -13.92 -9.56 3.11
Cash Conversion Cycle
97.43 82.31 84.28 69.95 94.83
Days of Sales Outstanding
70.75 74.96 70.76 64.80 70.30
Days of Inventory Outstanding
90.28 73.29 75.02 65.44 78.52
Days of Payables Outstanding
63.59 65.94 61.50 60.30 53.99
Operating Cycle
161.02 148.24 145.77 130.24 148.82
Cash Flow Ratios
Operating Cash Flow Per Share
10.65 12.92 14.08 12.87 10.55
Free Cash Flow Per Share
10.65 12.48 13.69 12.42 10.07
CapEx Per Share
0.00 0.44 0.39 0.44 0.48
Free Cash Flow to Operating Cash Flow
1.00 0.97 0.97 0.97 0.95
Dividend Paid and CapEx Coverage Ratio
1.71 2.02 2.32 2.27 2.07
Capital Expenditure Coverage Ratio
0.00 29.39 35.89 28.94 22.04
Operating Cash Flow Coverage Ratio
0.28 0.38 0.39 0.30 0.20
Operating Cash Flow to Sales Ratio
0.33 0.42 0.43 0.41 0.38
Free Cash Flow Yield
6.00%8.05%8.47%9.18%9.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
73.33 56.34 24.18 20.76 38.70
Price-to-Sales (P/S) Ratio
5.57 5.04 4.93 4.26 3.90
Price-to-Book (P/B) Ratio
94.34 26.45 16.59 15.55 13.66
Price-to-Free Cash Flow (P/FCF) Ratio
16.68 12.42 11.80 10.90 10.64
Price-to-Operating Cash Flow Ratio
16.68 12.00 11.47 10.52 10.16
Price-to-Earnings Growth (PEG) Ratio
-6.46 -0.96 9.22 0.15 -0.80
Price-to-Fair Value
94.34 26.45 16.59 15.55 13.66
Enterprise Value Multiple
25.17 18.52 10.83 10.84 12.12
Enterprise Value
EV to EBITDA
25.17 18.52 10.83 10.84 12.12
EV to Sales
6.66 5.90 5.86 5.46 5.59
EV to Free Cash Flow
19.96 14.53 14.03 13.94 15.26
EV to Operating Cash Flow
19.96 14.04 13.64 13.46 14.57
Tangible Book Value Per Share
-51.92 -43.84 -46.48 -52.48 -61.73
Shareholders’ Equity Per Share
1.88 5.86 9.74 8.71 7.84
Tax and Other Ratios
Effective Tax Rate
-0.15 0.22 0.12 0.11 0.36
Revenue Per Share
31.91 30.72 32.78 31.75 27.48
Net Income Per Share
2.42 2.75 6.68 6.52 2.77
Tax Burden
1.15 0.78 0.88 0.89 1.36
Interest Burden
0.57 0.73 0.86 0.84 0.58
Research & Development to Revenue
0.23 0.16 0.11 0.13 0.14
SG&A to Revenue
0.00 0.20 0.23 0.18 0.21
Stock-Based Compensation to Revenue
0.02 0.01 0.01 0.01 0.02
Income Quality
4.39 4.69 2.11 1.97 3.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis